VT-346

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVT-346
Drug Alias NameTNF-alpha binding protein (Viron)VT-300 series (Viron)cytokine binding proteins (Viron)VT-346
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTumor necrosis factor α inhibitors
TargetsTumor necrosis factor α
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesViron Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViron Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A